Skip to Main Content

Author Details

Balaji Manicassamy
University of Iowa
2002
67
35
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
37843369Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.J Virol2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
34851142Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.J Virol2022
35926068Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy.PLoS Pathog2022
36260129Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A Viruses.J Med Chem2022
33970958Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments.PLoS Pathog2021
33851166Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.bioRxiv2021
34473799Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes.PLoS Pathog2021
34466656Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity.ACS Cent Sci2021
34634664Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant.Biomaterials2021
32125535Varying Inoculum Dose to Assess the Roles of the Immune Response and Target Cell Depletion by the Pathogen in Control of Acute Viral Infections.Bull Math Biol2020
32075925Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.J Virol2020
32069052Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.J Med Chem2020
32898178The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.PLoS Pathog2020
32611549Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor.Life Sci Alliance2020
32117155Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.Front Microbiol2020
32222293Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.Antiviral Res2020
28933281Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.Curr Med Chem2018
29899269A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing <i>Gaussia</i> Luciferase.Viruses2018
29642015Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.Cell Rep2018
29032747Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.Curr Med Chem2018
29321057Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis.Microbiome2018
29268608Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.ACS Infect Dis2018
29141870Igβ ubiquitination activates PI3K signals required for endosomal sorting.J Exp Med2017
28282445Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species.PLoS Pathog2017
27183583Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine.J Immunol2016
26546155La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation.Virus Res2016
27759373Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless.ACS Infect Dis2016
27438481RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection.PLoS Pathog2016
25568183β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells.Cancer Res2015
26651948Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.Cell Host Microbe2015
27141399Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunity.Oncoimmunology2015
26153856Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.Nature2015
25710911Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.J Immunol2015
25428869Influenza A virus uses intercellular connections to spread to neighboring cells.J Virol2015
24284630Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.Nature2014
25210184Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.J Virol2014
24692634RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection.mBio2014
23720581Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.Sci Transl Med2013
23686828Insertion of a GFP reporter gene in influenza virus.Curr Protoc Microbiol2013
22419161Suppression of the antiviral response by an influenza histone mimic.Nature2012
23041628Cross-presenting CD103+ dendritic cells are protected from influenza virus infection.J Clin Invest2012
23056353Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells.PLoS One2012
22876275Host modulators of H1N1 cytopathogenicity.PLoS One2012
22674996Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential.J Virol2012
22312003Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export.J Cell Biol2012
21667336Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry.Virol Sin2011
21852950Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species.PLoS Pathog2011
  • 1 - 50 of 67

Recommended Authors

Stuart Weston
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 15
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 14
Brook E Heaton
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 4
Anshu P Gounder
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2012
Number of shared co-authors 9
Sebastian Giese
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 6
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 19
James Zengel
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 7
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 18
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 13
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 28
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 7
Yasuko Hatta
FluGen Inc.
Career Start Year 2007
Number of shared co-authors 0
Juan Ayllon
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 21
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 5
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 4
Shufang Fan
Influenza Research Institute, University of Wisconsin
Career Start Year 2006
Number of shared co-authors 7
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 11
Amber M Smith
University of California san francisco
Career Start Year 2006
Number of shared co-authors 8
Chengjun Li
Harbin Veterinary Research Institute
Career Start Year 2005
Number of shared co-authors 5
Man-Seong Park
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 8
Masato Hatta
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2000
Number of shared co-authors 7
Birgit Bradel-Tretheway
Washington State University
Career Start Year 2000
Number of shared co-authors 3
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 4
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 11
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 8
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 7
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 15
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 18
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 13

Collaborators

Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 29
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Rong Hai
University of California riverside
Co-authored papers 5
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 5
Charles M Rice
Rockefeller University
Co-authored papers 5
Silke Stertz
Institute of Medical Virology, University of Zurich
Co-authored papers 4
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Britt A Glaunsinger
UC Berkeley
Co-authored papers 3
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Stephen P Goff
Columbia University
Co-authored papers 3
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Michael Emerman
Fred Hutchinson Cancer Center
Co-authored papers 3
Jay A Nelson
Oregon Health and Science University
Co-authored papers 3
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Wesley I Sundquist
University of Utah School of Medicine
Co-authored papers 3
Nels C Elde
University of Utah School of Medicine
Co-authored papers 3
Andrew D Yurochko
Louisiana State University
Co-authored papers 3
Rolf Renne
Co-authored papers 3
Adam S Lauring
University of Michigan ann arbor
Co-authored papers 3
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers 3
Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Adrianus C M Boon
Co-authored papers 3
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers 3
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 3
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Andrew Pekosz
Co-authored papers 3
Release 1.2